Editorial: Combination Strategies in the Treatment of Melanoma

by Ascierto, Paolo Antonio
Published in Front Oncol (2016)

Melanoma: the role of surgery in the era of new therapies

by Mozzillo, Nicola, Ascierto, Paolo A
Published 2014

Immunological effects of BRAF+MEK inhibition

by Ascierto, Paolo A., Dummer, Reinhard
Published in Oncoimmunology (2018)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives

by Ascierto, Paolo Antonio, Schadendorf, Dirk
Published in Drugs Context (2019)

Adjuvant therapy of melanoma with interferon: lessons of the past decade

by Ascierto, Paolo A, Kirkwood, John M
Published 2008

Combination therapy: the next opportunity and challenge of medicine

by Ascierto, Paolo A, Marincola, Francesco M
Published 2011

What have we learned from cancer immunotherapy in the last 3 years?

by Ascierto, Paolo A, Marincola, Francesco M
Published 2014

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond

by Ascierto, Paolo A., Marincola, Francesco M.
Published in EBioMedicine (2015)

Perspectives on COVID-19 and cancer immunotherapy: a review series

by Goldman, Jason D, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2021)

Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?

by Ascierto, Paolo A., McArthur, Grant A.
Published in J Transl Med (2017)

What is changing in the adjuvant treatment of melanoma?

by Ascierto, Paolo A., Palmieri, Giuseppe, Gogas, Helen
Published in Oncotarget (2017)

IL-6 modulation for COVID-19: the right patients at the right time?

by Ascierto, Paolo Antonio, Fu, Binqing, Wei, Haiming
Published in J Immunother Cancer (2021)

Melanoma: A model for testing new agents in combination therapies

by Ascierto, Paolo A, Streicher, Howard Z, Sznol, Mario
Published 2010

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

by Ascierto, Paolo A, Marincola, Francesco M, Ribas, Antoni
Published 2011

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy

by Ascierto, Maria Libera, Melero, Ignacio, Ascierto, Paolo Antonio
Published in Front Oncol (2015)

Anti-IL6R role in treatment of COVID-19-related ARDS

by Buonaguro, Franco Maria, Puzanov, Igor, Ascierto, Paolo Antonio
Published in J Transl Med (2020)

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy

by Trojaniello, Claudia, Luke, Jason J., Ascierto, Paolo A.
Published in Front Oncol (2021)

What’s new in melanoma? Combination!

by Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Published in J Transl Med (2015)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma

by Palmieri, Giuseppe, Puzanov, Igor, Massi, Daniela, Ascierto, Paolo Antonio
Published in Front Oncol (2021)

NF-κB as potential target in the treatment of melanoma

by Madonna Gabriele, Ullman Claudio, Gentilcore Giusy, Palmieri Giuseppe, Ascierto Paolo
Published 2012-03-01